Krsnaa Diagnostics IPO GMP History
Krsnaa Diagnostics IPO has been listed on August 16, 2021 at a listing price of ₹1005.55, against the issue price of ₹954 — a gain of ₹51.55 (+5.4%). The GMP peaked at ₹450 on 4 August 2021 and reached a low of ₹0 on 30 July 2021. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Krsnaa Diagnostics IPO raised ₹1213.33 Cr. through its IPO at a price band of ₹933 to ₹954 per share, with a lot size of 15 shares. The IPO was open for subscription from 04 Aug 2021 to 06 Aug 2021.
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 7:18 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 16 Aug 2021 | ₹ 320 | — | 34% | — | — |
| 15 Aug 2021 | ₹ 320 | — | 34% | — | — |
| 14 Aug 2021 | ₹ 320 | — | 34% | — | — |
| 13 Aug 2021 | ₹ 320 | — | 34% | — | — |
| 12 Aug 2021 | ₹ 320 | — | 34% | — | — |
| 11 Aug 2021 | ₹ 320 | ▼ | 34% | — | — |
| 10 Aug 2021 | ₹ 380 | ▼ | 40% | — | — |
| 09 Aug 2021 | ₹ 440 | — | 46% | — | — |
| 08 Aug 2021 | ₹ 440 | — | 46% | — | — |
| 07 Aug 2021 | ₹ 440 | ▲ | 46% | — | — |
| 06 Aug 2021 | ₹ 380 | ▼ | 40% | — | — |
| 05 Aug 2021 | ₹ 400 | ▼ | 42% | — | — |
| 04 Aug 2021 | ₹ 450 | — | 47% | — | — |
| 03 Aug 2021 | ₹ 450 | ▲ | 47% | — | — |
| 02 Aug 2021 | ₹ 400 | ▼ | 42% | — | — |
| 01 Aug 2021 | ₹ 450 | — | 47% | — | — |
| 31 Jul 2021 | ₹ 450 | ▲ | 47% | — | — |
| 30 Jul 2021 | ₹ 0 | — | -- | — | — |
| 29 Jul 2021 | ₹ 0 | — | -- | — | — |
| 28 Jul 2021 | ₹ 0 | — | -- | — | — |
| 27 Jul 2021 | ₹ 0 | — | -- | — | — |
| 26 Jul 2021 | ₹ 0 | — | -- | — | — |
| 25 Jul 2021 | ₹ 0 | — | -- | — | — |
Krsnaa Diagnostics IPO dates
Key dates from opening to listing. Today is 14 November.
- Open 04 Aug 2021
- Close 06 Aug 2021
- Allotment 11 Aug 2021
- Refund/credit 12 Aug 2021
- Listing 16 Aug 2021
Krsnaa Diagnostics IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹954 |
|---|---|
| Listing gain / loss | +₹51.55 per share |
| Listing date | 16 Aug, 2021 |
| Actual listing price | ₹1005.55 (+5.4%) |
Is Krsnaa Diagnostics IPO GMP reliable?
Grey market premium for Krsnaa Diagnostics IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Krsnaa Diagnostics IPO full review for a fundamentals-based assessment before making any grey market trades.
Krsnaa Diagnostics IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Krsnaa Diagnostics IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Krsnaa Diagnostics IPO
Krsnaa Diagnostics Limited was incorporated as Krsna Diagnostics Private Limited at Pune on 22 December 2010. It provides technology-enabled imaging, radiology, pathology and tele-radiology services to public and private hospitals, medical colleges and community health centres.
It focuses on the public private partnership diagnostics segment and on non-metro and smaller cities. It runs one of India's largest tele-radiology reporting hubs in Pune, which reads X-rays, CT scans and MRI scans round the clock.
On 31 December 2020 it ran 1,801 diagnostic centres, with a footprint in 13 states. It has served more than 23 million patients since inception, including 5.27 million patients in fiscal 2020.
The IPO was Rs 1,213.33 crore, with Rs 400.84 crore of fresh issue and Rs 812.49 crore of offer for sale by investors Phi Capital, Kitara and Somerset. Rs 150.81 crore was planned for new diagnostic centres and Rs 146.08 crore for repaying borrowings.
Frequently asked
What is the GMP of Krsnaa Diagnostics IPO?
The current Grey Market Premium (GMP) of Krsnaa Diagnostics IPO is not yet started or active in the market.
What is the Kostak Price of Krsnaa Diagnostics IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Krsnaa Diagnostics IPO is not available.
What is the Subject to Sauda Price of Krsnaa Diagnostics IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Krsnaa Diagnostics IPO?
Krsnaa Diagnostics IPO listed on August 16, 2021 at ₹1005.55, against the issue price of ₹954 — a gain of +5.4%.
How did the GMP of Krsnaa Diagnostics IPO trend before listing?
The GMP of Krsnaa Diagnostics IPO was stable in its final days before listing. The GMP peaked at ₹450 on 4 August 2021. View the day-wise table above for the complete GMP history.
Explore Krsnaa Diagnostics IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.